MARATTO

article · Folia veterinaria

Protective Effects of Piroxicam Against Anthracene-Induced Haematological and Biochemical Alteration in Female Rats

Abstract

Abstract The study aimed to evaluate the protective effects of piroxicam and carboplatin against anthracene-induced haematological and biochemical alterations in female rats using randomized controlled trial. Thirty-six female rats of seven weeks old that weighed 166.25 ± 26.79 g divided into six groups of six each per group were used for the study. Each of the rats of group 1, 3, 4, 5 and 6 was administered 100 mg/kg of oral anthracene, for three weeks, except group 2, which was administered 2.5 mg/kg of water. Thereafter, each rat in groups 1 and 2 was administered water, group 3 (piroxicam low dose), group 4 (carboplatin/piroxicam), group 5 (piroxicam high dose) and group 6 (carboplatin) for a period of three weeks. Blood sample (2 ml) was collected from each rat for haematology and serum biochemistry. The rats were euthanised using 100 mg/kg of sodium pentobarbitone. Body weight, packed cell volume, erythrocyte, leucocyte and neutrophil counts were significantly decreased (p < 0.05), causing emaciation, anaemia, and immunodepression. Lymphocytes, monocytes, basophils, and eosinophils were significantly increased (p < 0.05) causing immunostimulation. Urea, creatinine, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase were significantly decreased (p < 0.05), indicating malnutrition, reduced kidney and liver functions.

Research topics

  • Carcinogens and Genotoxicity Assessment
  • Cassava research and cyanide
  • Pesticide Exposure and Toxicity

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2478/fv-2026-0004

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.